Evidence map›Paper›PMID 42094683›Full record

ArticleGastro hep advances2026

Significant Increase in

Jonathan Besney, Christina M Ray, Katherine A Buhler, Satchel Krawchuk, Humberto Jijon, Cathy Lu, Cynthia H Seow, Kerri L Novak, Joelle St-Pierre, Siddharth Singh and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jonathan BesneyDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Christina M RayDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Katherine A BuhlerDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Satchel KrawchukFaculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
Humberto JijonDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Cathy LuDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Cynthia H SeowDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Kerri L NovakDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Joelle St-PierreDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Siddharth SinghDivision of Gastroenterology, University of California San Diego, La Jolla, California.
Remo PanaccioneDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Gilaad G KaplanDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Christopher MaDivision of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Methods: Data from the National Inpatient Sample between January 2018 and December 2020 were analyzed. Temporal trends in admissions before and after the pandemic for CDI were analyzed using survey-adjusted Poisson regression and compared to hospitalizations for patients admitted for stroke and inflammatory bowel disease as controls. Univariable and multivariable logistic regression was used to evaluate mortality in CDI-associated admissions before and after the pandemic, adjusting for COVID-19. A bidirectional relationship was also explored, evaluating mortality in COVID-19-related admissions complicated by CDI. Results: Rates of CDI-related hospitalizations decreased marginally during the pandemic (incidence rate ratio 0.94 [95% confidence interval [CI]: 0.93-0.96], Conclusion: Significantly increased risks of mortality were observed in CDI-associated hospitalizations with concomitant COVID-19 and vice versa.

Indexed as

C difficileClostridiumCOVID-19DeathEpidemiologyInpatient

Identifiers

PMID42094683
PMCPMC13141497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.